Cardiovascular Drugs Linked to Lower Dementia Risk, Study Finds

A recent study by Karolinska Institutet, published in *Alzheimer's & Dementia: The Journal of the Alzheimer's Association*, highlights a promising link between common cardiovascular drugs and a reduced risk of dementia. **Cardiovascular diseases and dementia pose significant healthcare challenges and societal burdens,** making these findings particularly impactful. The research utilized extensive Swedish national registers to examine data from around 88,000 individuals diagnosed with dementia between 2011 and 2016, along with 880,000 control subjects over the age of 70. **By focusing on widely used cardiovascular drugs – including antihypertensive drugs, cholesterol-lowering drugs, diuretics, and blood-thinning drugs –** the study found a reduction in dementia risk associated with long-term use of these medications. **The reductions ranged from 4% to 25%, with combinations of the drugs exhibiting stronger protective effects than standalone use.** One of the key findings was that antiplatelet drugs, often prescribed for stroke prevention, might conversely raise the risk of dementia. These drugs could lead to microbleeds in the brain, which are known to contribute to cognitive decline. The study's authors, including Mozhu Ding and Alexandra Wennberg, emphasize the need for further research to better understand these relationships, particularly through randomized controlled clinical trials. This could pave the way for innovative preventive strategies against dementia, which lacks a current cure. Additionally, the researchers plan to explore other factors, such as diet and lifestyle, that might impact dementia risk alongside cardiovascular medication use.